124 related articles for article (PubMed ID: 34029660)
1. Enhancement of immune responses by co-stimulation of TLR3 - TLR7 agonists as a potential therapeutics against rabies in mouse model.
Farahtaj F; Gholami A; Khosravy MS; Gharibzadeh S; Niknam HM; Ghaemi A
Microb Pathog; 2021 Aug; 157():104971. PubMed ID: 34029660
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of Toll-like receptor 3 signaling on pathogenesis of rabies virus in mouse model.
Sardana S; Singh KP; Saminathan M; Vineetha S; Panda S; Dinesh M; Maity M; Varshney R; Sulabh S; Sahoo M; Dutt T
Acta Trop; 2022 Oct; 234():106589. PubMed ID: 35809612
[TBL] [Abstract][Full Text] [Related]
3. Dual Role of Toll-Like Receptor 7 in the Pathogenesis of Rabies Virus in a Mouse Model.
Luo Z; Lv L; Li Y; Sui B; Wu Q; Zhang Y; Pei J; Li M; Zhou M; Hooper DC; Fu ZF; Zhao L
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102880
[TBL] [Abstract][Full Text] [Related]
4. Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice.
Liu R; Wang J; Yang Y; Khan I; Zhu N
Virology; 2016 Oct; 497():102-110. PubMed ID: 27449478
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification and functional expression of porcine Toll-like receptor (TLR) 3 and TLR7.
Sang Y; Yang J; Ross CR; Rowland RR; Blecha F
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):162-7. PubMed ID: 18533275
[TBL] [Abstract][Full Text] [Related]
6. Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice.
Lin Y; Ren L; Wang W; Di J; Zeng S; Saito S
J Reprod Immunol; 2009 Oct; 82(1):12-23. PubMed ID: 19560213
[TBL] [Abstract][Full Text] [Related]
7. Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques.
Sariol CA; Martínez MI; Rivera F; Rodríguez IV; Pantoja P; Abel K; Arana T; Giavedoni L; Hodara V; White LJ; Angleró YI; Montaner LJ; Kraiselburd EN
PLoS One; 2011 Apr; 6(4):e19323. PubMed ID: 21559444
[TBL] [Abstract][Full Text] [Related]
8. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
9. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
[TBL] [Abstract][Full Text] [Related]
11. TLR3 and TLR7 are involved in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-beta by Theiler's virus-infected RAW264.7 cells.
Al-Salleeh F; Petro TM
Microbes Infect; 2007 Sep; 9(11):1384-92. PubMed ID: 17897860
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 7 Enhances Rabies Virus-Induced Humoral Immunity by Facilitating the Formation of Germinal Centers.
Luo Z; Li Y; Zhou M; Lv L; Wu Q; Chen C; Zhang Y; Sui B; Tu C; Cui M; Chen H; Fu ZF; Zhao L
Front Immunol; 2019; 10():429. PubMed ID: 30906301
[TBL] [Abstract][Full Text] [Related]
13. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
14. Differential chemokine and cytokine production by neonatal bovine γδ T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection.
McGill JL; Nonnecke BJ; Lippolis JD; Reinhardt TA; Sacco RE
Immunology; 2013 Jun; 139(2):227-44. PubMed ID: 23368631
[TBL] [Abstract][Full Text] [Related]
15. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
[TBL] [Abstract][Full Text] [Related]
16. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
17. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
Duechs MJ; Hahn C; Benediktus E; Werner-Klein M; Braun A; Hoymann HG; Gantner F; Erb KJ
Pulm Pharmacol Ther; 2011 Apr; 24(2):203-14. PubMed ID: 21195789
[TBL] [Abstract][Full Text] [Related]
18. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
19. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
[TBL] [Abstract][Full Text] [Related]
20. TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection.
Jin YH; Kaneyama T; Kang MH; Kang HS; Koh CS; Kim BS
J Neuroinflammation; 2011 Dec; 8():178. PubMed ID: 22189096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
